Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-22

FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for clonazepam from Par Health USA, LLC under an ANDA, signaling approval of a supplemental filing for a generic clo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)